Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: NU position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on NU, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 4,689,670 NU shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,689,670 shares
    Change vs previous 13F +496,718 shares

    1.15% of the 13F portfolio, value $62,653,991.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,192,952 shares
    Change vs previous 13F +785,026 shares

    1.16% of the 13F portfolio, value $60,252,720.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,407,926 shares
    Change vs previous 13F -84,291 shares

    1.2% of the 13F portfolio, value $57,052,959.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,492,217 shares
    Change vs previous 13F +957,531 shares

    1.25% of the 13F portfolio, value $55,914,612.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,534,686 shares
    Change vs previous 13F +2,501,647 shares

    1.08% of the 13F portfolio, value $34,778,545.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 33,039 shares
    Change vs previous 13F +11,883 shares

    0.01% of the 13F portfolio, value $338,347.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 21,156 shares
    Change vs previous 13F +5,739 shares

    0.01% of the 13F portfolio, value $219,194.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 15,417 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $210,457.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).